Gibbon ape leukemia virus envelope glycoprotein (GaLV-Env) (GaLV-Env)

The Gibbon ape leukemia virus envelope glycoprotein (GaLV-Env) is a Class I viral fusion protein that mediates the entry of the Gibbon ape leukemia virus into host cells (UniProt: P03395). It functions by binding specifically to the human sodium-dependent phosphate transporter 1 (PiT-1), encoded by the SLC20A1 gene, which triggers a conformational change in the glycoprotein to facilitate membrane fusion (Johann et al., 1992). In modern biotechnology, GaLV-Env is a critical tool for pseudotyping retroviral and lentiviral vectors, significantly improving the transduction efficiency of human hematopoietic stem cells and other therapeutic targets (Miller et al., 1991). Beyond its role as a delivery vehicle, the protein is utilized in oncolytic virotherapy as a fusogenic membrane glycoprotein (FMG) to induce potent anti-tumor effects. When expressed in malignant cells, GaLV-Env promotes the formation of large, multinucleated syncytia, leading to cell death and the release of tumor-associated antigens that stimulate a systemic immune response (Bateman et al., 2000). This bystander killing mechanism allows for the destruction of neighboring cancer cells that were not directly transduced, making it a promising candidate for enhancing the efficacy of gene-based cancer therapies (Galanis et al., 2001).

Other names

GaLV fusogenic membrane glycoproteinGaLV-EnvGibbon ape leukemia virus fusogenic glycoproteinFMG

Induces syncytia formation and subsequent cell death through membrane fusion with neighboring cells expressing the PiT-1 receptor.